
Bringing Discoveries to Life: Technology Transfer at UAMS
Every breakthrough at the University of Arkansas for Medical Sciences (UAMS) starts the same way: a question, an experiment, a
Linking research minds with global markets
BioVentures, as the technology transfer office of the University of Arkansas for Medical Sciences (UAMS), is responsible for managing the intellectual property generated at the institution. Our team, made up of experts in licensing, business development, healthcare sciences, and legal matters, assists inventors and startups in commercializing their technology, thereby contributing to regional economic and social development.
Submit your invention disclosure here and initiate the journey towards commercialization
Learn how to obtain a patent, policies and procedures, and other important details for inventors.
Browse through our intellectual property portfolio and discover the available technology.
Identification, protection, and management of intellectual property (IP) generated from research activities. This includes patent filing and maintenance, copyright registration, and trademark protection.
Development of licensing strategies, negotiation of licensing agreements, and oversight of existing agreements to ensure compliance and manage royalties.
Assistance in the development of commercialization strategies for new technologies, including market analysis and business model development.
Providing support for new business creation, including entrepreneurial guidance, access to incubator space, and connecting to potential investors.
Assistance in identifying and applying for grants and other funding sources to support the development and commercialization of technologies.
Building and managing relationships with industry partners to facilitate research collaborations, co-development projects, and technology licensing.
Ensuring that technology development and commercialization activities comply with relevant laws, regulations, and institutional policies.
Programs for UAMS faculty, trainees, and staff on the IP process, commercialization options, and entrepreneurship.
Every breakthrough at the University of Arkansas for Medical Sciences (UAMS) starts the same way: a question, an experiment, a
BioVentures recently took part in the 2025 Arkansas Commercialization Retreat, held June 2–4 at the Winthrop Rockefeller Institute. Organized by
BioVentures LLC has adopted Tradespace, an AI-driven platform built specifically for technology-transfer offices, to streamline invention disclosures and commercialization efforts